Stockreport

BioLineRx Strengthens Intellectual Property Estate with Notice of Allowance for U.S. Patent Covering Method of Manufacturing Motixafortide (BL-8040) Suitable for Large Scale Production

BioLineRx Ltd. - American Depositary Shares  (BLRX) 
Last biolinerx ltd. - american depositary shares earnings: 5/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.biolinerx.com
PDF - New patent, when issued, will be valid until December 2041 -- Additional IP complements U.S. market exclusivity awarded to BioLineRx upon FDA approval of APHEXDA® (mot [Read more]